4.1 Article

Thrombogenicity of Hyaluronic Acid Fillers: A Quantitative Thrombodynamics Study

Journal

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
Volume 38, Issue 1, Pages 68-72

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/IOP.0000000000001990

Keywords

-

Ask authors/readers for more resources

This study quantitatively analyzed the thrombogenicity of two commonly used hyaluronic acid fillers. The results showed that Juvederm significantly reduces the initial rate of clot growth, the average rate of clot growth over 30 minutes, and clot size, while the addition of Restylane decreases the average rate of clot growth without affecting overall clot size in healthy individuals.
Purpose: At present, there is a paucity of data regarding the thrombogenicity of hyaluronic acid fillers (HAFs). This article quantitatively analyses the thrombogenicity of 2 commonly used HAFs: Restylane Lyft and Juvederm Ultra. Methods: Thrombogenicity was assessed using the Thrombodynamics Analyzer System and plasma obtained from healthy controls. Following the addition of HAFs or control, spontaneous clot formation time, initial rate of clot growth, average rate of clot growth over 30 minutes, and clot size at 30 minutes was measured for each sample. The median of differences between each group were analyzed. Results: Nine individuals with a mean (SD) age of 37 (17) years, participated in the study. Initial rate of clot growth was significantly lower in plasma mixed with Juvederm compared to control (p = 0.008) or Restylane (p = 0.038). The average rate of clot growth more than 30 minutes was significantly lower in both HAF groups (Restylane vs. control p = 0.038; Juvederm vs. control p = 0.008), there was no significant difference between HAF groups (p = 0.635). Final clot size was significantly smaller with Juvederm (p = 0.038 vs. control and p = 0.013 vs. Restylane). Spontaneous clot formation time did not significantly change with the addition of either HAF. Conclusions: Juvederm significantly reduces the initial rate of clot growth, the average rate of clot growth more than 30 minutes, and clot size, whereas the addition of Restylane decreases the average rate of clot growth without affecting overall clot size in healthy individuals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Corneal Neurotization for Postherpetic Neurotrophic Keratopathy: Initial Experience and Clinical Outcomes

Jane S. Kim, Leon Rafailov, Ilya M. Leyngold

Summary: Corneal neurotization is effective in improving corneal sensation and promoting corneal healing in patients with postherpetic neurotrophic keratopathy. Additionally, it can enhance visual acuity in these patients.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2021)

Letter Dermatology

Melanin and erythema values before and after bilateral transconjunctival lower lid blepharoplasty with ablative lower lid carbon dioxide laser (CO2) skin resurfacing

Roshni U. Ranjit-Reeves, Atalie C. Thompson, Leon Rafailov, Jane S. Kim, Julie A. Woodward

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)

Article Ophthalmology

Patient Satisfaction and Management of Postoperative Complications Following Ablative Carbon Dioxide Laser Resurfacing of the Lower Eyelids

Jane S. Kim, Anna Ginter, Roshni Ranjit-Reeves, Julie A. Woodward

Summary: Ablative carbon dioxide laser resurfacing of the lower eyelids can provide excellent aesthetic results with high patient satisfaction and low complication rates. Timely and proper management of postoperative complications is essential for maximizing successful cosmetic outcomes.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2021)

Review Clinical Neurology

Masses of the Lacrimal Gland: Evaluation and Treatment

Jane S. Kim, Jason Liss

Summary: Lesions of the lacrimal gland can be caused by various factors, including inflammatory and lymphoproliferative disorders, benign and malignant epithelial tumors. Benign tumors are usually unilateral, while a rapid onset of symptoms and periorbital pain may indicate malignant disease. A good understanding of common clinical characteristics and radiographic imaging findings is essential for diagnosis and treatment.

JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2021)

Article Ophthalmology

Clinical Outcomes and Patient Satisfaction After Corneal Neurotization

Leon Rafailov, Jane S. Kim, Clayton Ellis Wisely, Edgar M. Espana, Matias Soifer, Ilya M. Leyngold

Summary: Corneal neurotization (CN) provides improvement in corneal health and sensibility, with high patient satisfaction and minimal postoperative pain and morbidity.

CORNEA (2021)

Article Ophthalmology

Multiple Cranial Neuropathies as the Initial Presentation of Primary Ductal Adenocarcinoma of the Lacrimal Gland

Jane S. Kim, Alan D. Proia, Jason Liss, Joel Morgenlander, Landon C. Meekins

Summary: Primary ductal adenocarcinoma of the lacrimal gland is a rare and aggressive malignancy that presents with symptoms such as proptosis, pain, and vision problems. In rare cases, it may first present with multiple cranial neuropathies. A targeted diagnostic evaluation involving clinical history, examination, and neuroimaging, as well as repeat biopsy or complete excision of the lacrimal gland, may be necessary for accurate diagnosis.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2022)

Article Surgery

Changes to Eye Whiteness and Eyelid/Brow Position With Topical Oxymetazoline in Aesthetic Patients

Shoaib Ugradar, Jane S. Kim, Noelle Trost, Emanuil Parunakian, Erin Zimmerman, Kambiz Ameli, Marissa K. Shoji, Wendy W. Lee

Summary: This study assessed the effects of oxymetazoline hydrochloride 0.1% ophthalmic solution on upper and lower eyelid position, brow position, and sclera color in patients with ptosis. The results showed that within 2 hours of treatment, oxymetazoline significantly improved eyelid aperture size and made the eyes appear whiter.

AESTHETIC SURGERY JOURNAL (2022)

Editorial Material Ophthalmology

Progressively Worsening Unilateral Ptosis in a Woman in Her 60s

Jane S. Kim, Jonathan D. Trobe, Shannon S. Joseph

Summary: A woman in her 60s with a history of hyperlipidemia, hypothyroidism, and chronic migraines presented with progressively worsening left-sided ptosis. Examination revealed mild fullness in the left superior sulcus and mildly increased left-sided resistance to retropulsion. What would you do next?

JAMA OPHTHALMOLOGY (2022)

Article Ophthalmology

Inferior altitudinal visual loss and mask-wearing practices: A case series

Cynthia A. Boxrud, Nicholas A. Householder, Dylan K. Kim, Katherine M. Kugler, Chandler S. Harris, Brooke P. Benjamin, Alexa H. Panrudkevich, Gavin G. Bahadur

Summary: Face mask-wearing practices have an impact on the visual field, especially during the COVID-19 pandemic. This study examined the visual field of 10 participants using different types of masks and found that wearing duckbill N95 masks was associated with increased errors in the lower visual field compared to wearing surgical masks or no masks. These findings support the previous guidance on the risks of falls and accidents related to face mask wearing.

INDIAN JOURNAL OF OPHTHALMOLOGY (2023)

Review Orthopedics

A Review of Recent Innovations in Cartilage Regeneration Strategies for the Treatment of Primary Osteoarthritis of the Knee: Intra-articular Injections

Nicholas A. Householder, Akshay Raghuram, Kofi Agyare, Skyler Thipaphay, Mimi Zumwalt

Summary: This article reviews the current research on experimental injections aimed at achieving cellular restoration of the hyaline cartilage tissue of the knee joint. The most promising intra-articular injections for the treatment of primary osteoarthritis include bioengineered advanced-delivery steroid-hydrogel preparations, ex vivo expanded allogeneic stem cell injections, genetically engineered chondrocyte injections, recombinant fibroblast growth factor therapy, injections of selective proteinase inhibitors, senolytic therapy via injections, injectable antioxidant therapies, injections of Wnt pathway inhibitors, injections of nuclear factor-kappa beta inhibitors, injections of modified human angiopoietin-like-3, various potential viral vector-based genetic therapy approaches, and RNA genetic technology administered via injections.

ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE (2023)

Article Ophthalmology

Efficacy of lateral orbital rim decompression in patients with prior rim-sparing, three-wall orbital decompression

Bradford W. Lee, Jane S. Kim, Richard L. Scawn, Bobby S. Korn, Don O. Kikkawa

Summary: This study retrospectively analyzed the effects of removal of the lateral orbital rim in patients with residual symptomatic proptosis after three-wall decompression for thyroid eye disease. The results showed that removal of the lateral orbital rim can effectively reduce the degree of proptosis without significant complications.

TAIWAN JOURNAL OF OPHTHALMOLOGY (2022)

Article Ophthalmology

Malignant Orbital Tumors: Current Approach to Diagnosis and Management

Jane S. Kim, Amal Al-Lozi, Ilya M. Leyngold

Summary: Malignant orbital masses can be caused by a variety of pathologies, including primary tumors, mesenchymal tumors, optic nerve tumors, lymphoproliferative disorders, and secondary tumors. Clinical knowledge and imaging findings are necessary to make a correct diagnosis and provide appropriate treatment. Treatment plans should be determined based on clinical stage and histological grade of the tumor.

CURRENT OPHTHALMOLOGY REPORTS (2021)

No Data Available